Figure 3.
PRO-C20 in cohort 1 according to cancer stage. Quantification of PRO-C20 in cohort 1 was stratified into cancer types and plotted as a function of cancer stage. Biomarker levels are presented as Tukey-style boxplots with datapoint jitter. Differences in PRO-C20 according to cancer stage in each cancer type was evaluated by ordinary ANOVA.